Alumis Inc. is a publicly traded biotechnology company developing targeted therapies for immune-mediated diseases. The website emphasizes a precision approach to replace broad immunosuppression, with a pipeline built through a merger with Acelyrin. Contact information includes a South San Francisco phone number and a New Jersey address, consistent with a biopharma firm.
Filed August 26, 2025 · Manhattan, NY
Your competitors in Manhattan are getting unlimited new business leads.
ALUMIS INC. is a biotechnology business (Corp) registered on August 26, 2025 with the New York Division of Corporations. The business is located in Manhattan, New York.
Get owner name, phone, email, and website for newly registered businesses delivered to your inbox daily.
Start Your Free Trial ›Filing timeline will be available soon.
ALUMIS INC. was registered as Corp on August 26, 2025 in New York.
ALUMIS INC.'s principal address on file is Manhattan, NY, 10005.
ALUMIS INC. is classified as a biotechnology business (precision immunology).
No EIN was found on file for ALUMIS INC. at the time of registration.
Based on the business category, these service providers typically target this type of business.